Advarra Launches Innovative Collaboration Solution to Enhance Clinical Trial Efficiency
In a major leap forward for clinical trials, Advarra has unveiled its new Study Collaboration solution, a comprehensive system designed to streamline site activation processes and foster enhanced communication among all stakeholders involved in clinical research. As the leader in regulatory review solutions and clinical research technology, Advarra’s latest offering aims to tackle the persistent challenges associated with study startup, such as delays caused by manual information exchanges and disconnected processes.
This solution integrates Advarra's existing clinical trial management technologies with the innovative Longboat technology acquired in 2020. As a result, it now benefits more than 225,000 users across the globe. By enabling seamless collaboration throughout critical phases like feasibility assessments, document exchanges, site training, and enrollment planning, the Study Collaboration solution aims to significantly reduce the time from site selection to patient recruitment.
The service includes two key components: Advarra Study Startup (SSU) and Advarra Enroll, which work in harmony to guide research teams through the site activation journey. These tools are developed as part of a sustained technology investment, intended to improve both speed and compliance in site activation processes.
Ashley Davidson, the vice president responsible for product development in sponsor technology strategy, emphasized the necessity for such innovations by highlighting the inefficiencies that exist in the current clinical trial landscape. She pointed out that manual processes can obstruct coordination and transparency, leading to cascading delays throughout the study timeline. Research indicates that a staggering 80% of trials struggle to enroll patients on time, underscoring the urgent need for a solution that enhances operational efficiencies.
The Study Collaboration solution provides real-time visibility of activation and enrollment progress across multiple sites. Notably, it allows both investigative sites and sponsor teams to access the entire startup workflow using their own credentials, thus reducing administrative burdens and amplifying engagement among participants.
Key industry players have already recognized the tangible benefits of Advarra’s innovations. Deb Tatton, president of global clinical and data operations at Parexel, remarked on the importance of enhancing collaboration with investigative sites, noting how Advarra's integrated system effectively combines various tasks—including training and document management—into one user-friendly format. The introduction of the 'Advarra One' single sign-on system further simplifies access for clinical research professionals.
Nancy Cleverley, senior vice president of operations management at the Alliance for Multispecialty Research (AMR), also praised the solution, highlighting its potential to provide site staff with more engaging study training experiences. By automating tasks like document routing between electronic trial master file systems and electronic investigator site file platforms, Advarra contributes to a more efficient research environment.
“Advarra’s technology reduces the complexities and redundancies in study startup activities,” remarked Denise Snyder, associate dean for clinical research at Duke University School of Medicine. This simplified approach does not only save time but also plays a vital role in shortening activation timelines, a crucial necessity for modern clinical trials.
The competitive landscape of clinical research demands quick adaptability, making such innovations crucial for success. Advarra’s Study Collaboration solution aims to revolutionize the way clinical research is conducted, ensuring that new therapies reach patients faster and more efficiently.
For those interested in learning more, Advarra will showcase its Study Collaboration solution at the upcoming SCOPE Summit scheduled for February 3–6, 2025, at Booth #1003. This event presents a fantastic opportunity for professionals in the clinical research field to explore groundbreaking technologies designed to improve trial efficiency and efficacy.
Advarra continues to lead the charge in breaking down silos in clinical research, facilitating better collaboration among patients, sites, sponsors, and clinical research organizations. Its commitment to ensuring trial compliance and advancing healthcare technology positions the company at the forefront of clinical research innovation. To discover more about Advarra and its transformative offerings, please visit their official website at advarra.com.
This solution integrates Advarra's existing clinical trial management technologies with the innovative Longboat technology acquired in 2020. As a result, it now benefits more than 225,000 users across the globe. By enabling seamless collaboration throughout critical phases like feasibility assessments, document exchanges, site training, and enrollment planning, the Study Collaboration solution aims to significantly reduce the time from site selection to patient recruitment.
The service includes two key components: Advarra Study Startup (SSU) and Advarra Enroll, which work in harmony to guide research teams through the site activation journey. These tools are developed as part of a sustained technology investment, intended to improve both speed and compliance in site activation processes.
Ashley Davidson, the vice president responsible for product development in sponsor technology strategy, emphasized the necessity for such innovations by highlighting the inefficiencies that exist in the current clinical trial landscape. She pointed out that manual processes can obstruct coordination and transparency, leading to cascading delays throughout the study timeline. Research indicates that a staggering 80% of trials struggle to enroll patients on time, underscoring the urgent need for a solution that enhances operational efficiencies.
The Study Collaboration solution provides real-time visibility of activation and enrollment progress across multiple sites. Notably, it allows both investigative sites and sponsor teams to access the entire startup workflow using their own credentials, thus reducing administrative burdens and amplifying engagement among participants.
Key industry players have already recognized the tangible benefits of Advarra’s innovations. Deb Tatton, president of global clinical and data operations at Parexel, remarked on the importance of enhancing collaboration with investigative sites, noting how Advarra's integrated system effectively combines various tasks—including training and document management—into one user-friendly format. The introduction of the 'Advarra One' single sign-on system further simplifies access for clinical research professionals.
Nancy Cleverley, senior vice president of operations management at the Alliance for Multispecialty Research (AMR), also praised the solution, highlighting its potential to provide site staff with more engaging study training experiences. By automating tasks like document routing between electronic trial master file systems and electronic investigator site file platforms, Advarra contributes to a more efficient research environment.
“Advarra’s technology reduces the complexities and redundancies in study startup activities,” remarked Denise Snyder, associate dean for clinical research at Duke University School of Medicine. This simplified approach does not only save time but also plays a vital role in shortening activation timelines, a crucial necessity for modern clinical trials.
The competitive landscape of clinical research demands quick adaptability, making such innovations crucial for success. Advarra’s Study Collaboration solution aims to revolutionize the way clinical research is conducted, ensuring that new therapies reach patients faster and more efficiently.
For those interested in learning more, Advarra will showcase its Study Collaboration solution at the upcoming SCOPE Summit scheduled for February 3–6, 2025, at Booth #1003. This event presents a fantastic opportunity for professionals in the clinical research field to explore groundbreaking technologies designed to improve trial efficiency and efficacy.
Advarra continues to lead the charge in breaking down silos in clinical research, facilitating better collaboration among patients, sites, sponsors, and clinical research organizations. Its commitment to ensuring trial compliance and advancing healthcare technology positions the company at the forefront of clinical research innovation. To discover more about Advarra and its transformative offerings, please visit their official website at advarra.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.